Answers are grounded in this paper and cite their sources.
Early and accurate detection of cancer cells is very important for improving cancer diagnosis and the effectiveness of treatment in the medical field. Consequently, the development of highly sensitive, label-free, and cost-effective optical biosensors has attracted significant research interest. Motivated by this growing demand, we proposed a butterfly-shaped hybrid circular dual-core photonic crystal fiber (BHCD-PCF)-based surface plasmon resonance (SPR) sensor for the detection of skin cancer (Basal), cervical cancer (HeLa), and blood cancer (Jurkat) cells. The proposed BHCD-PCF-SPR sensor features a simple structural design with circular air holes, facilitating fabrication. Numerical investigations were carried out using the finite element method (FEM) by considering the refractive index (RI) variations between healthy and cancerous cells. The optimized BHCD-PCF-SPR achieved a maximum wavelength sensitivity (WS) of 20,833.33 nm/RIU, and amplitude sensitivity (AS) of 1586.15 RIU−1. The results demonstrate an optimized BHCD-PCF-SPR capable of detecting healthy and cancerous cells by distinguishing between them based on RI. A comparative detection capability even for small changes in the RI. Overall, the high sensitivity, excellent detection capabilities, and simple structural design of the proposed BHCD-PCF-SPR sensor can be considered a promising technology for cancer cell detection and future biomedical sensing applications.
No takes yet. Share an insight, caveat, or question.
Khatun et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: